Muehrcke D D, Cornhill J F, Thomas J D, Cosgrove D M
Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Ohio 44194, USA.
J Card Surg. 1995 Jul;10(4 Suppl):514-9. doi: 10.1111/j.1540-8191.1995.tb00687.x.
Atheroembolism from the ascending aorta is an emerging cause of noncardiac complications after open heart surgery. We designed a new arterial cannula specifically to reduce the exit force and velocity of blood flow, thereby reducing the "sandblasting" effect of the exiting blood jet. The cannula has a closed tip and an internal cone that diffuses blood flow such that it enters the aorta via multiple side holes. Fluid dynamics of the cannula were tested against five frequently used cannulae: Sarns High-Flow (3M Sarns High-Flow, Ann Arbor, MI, USA), DLP 83024 (DLP Inc., Grand Rapids, MI, USA), RMI ARS 024C (Research Medical Inc. of Research Industries Corp., Midvale, UT, USA), Bard 1966 (C.R. Bard Inc., Haverhill, MA, USA), and Argyle THI (Sherwood Medical Co. Sub American Home Products Corp., St. Louis, MO, USA). All cannulae had an 8.0-mm external diameter. The new cannula demonstrated a similar pressure drop and internal tip diameter as the others. The exit force (newtons) of the Soft Flow cannula was significantly less than the Sarns High-Flow (p < 0.05), DLP (p < 0.001), RMI (p < 0.01), Bard (p < 0.001), and the Argyle (p < 0.001) cannulae. Peak velocity (cm/s) of the Soft Flow cannula was significantly less than the DLP (p < 0.01), RMI (p < 0.01), Bard (p < 0.01), and Argyle (p < 0.001). The cannulae all had similar hemolysis rates. The new arterial cannula produced the lowest exit force and flow velocity with no increase in hemolysis and may help to decrease the incidence of atheroemboli and its sequelae.
